According to the company, TULIP 2 was the second
phase III trial designed to assess the safety and efficacy of anifrolumab as a treatment for adults with moderate-to-severe SLE.
A
phase III trial has indicated that Lynparza maintenance therapy decreased risk of disease progression or death by 70% in patients with newly-diagnosed, advanced BRCA-mutated (BRACm) ovarian cancer, it was reported on Monday.
The
Phase III trial was designed to support full approval of ASP0113 for the prevention of CMV reactivation in CMV seropositive HCT recipients.
Bristol Myers Squibb, a global biopharmaceutical company, has reported positive results from a
Phase III trial (CheckMate -066) comparing an investigational PD-1 immune checkpoint inhibitor, Opdivo, to the chemotherapy, dacarbazine, in patients with treatment naive BRAF wild-type advanced melanoma, it was reported yesterday.
As a result of lessons learned in the randomized phase II study, the
phase III trial will be restricted to patients with lymph node-positive tumors who are clinically disease-free after completing standard therapy Only patients with low levels of HER2 expression, meaning immunohisrochemistry 1+ or 2+, will be eligible.
In addition, AstraZeneca said that TC-5214 failed to meet the primary endpoint in a second of four
Phase III trials under the so-called RENAISSANCE development programme.
Four other
phase III trials of dimebon (proposed generic name latrepirdfne) are currently enrolling patients.
Osiris recently completed enrollment in a
Phase III trial evaluating Prochymal for the treatment of steroid-refractory acute graft versus host disease (GvHD).
This monoclonal antibody will possibly be the next available therapeutic monoclonal antibody if an acceptable safety profile is confirmed in the two
Phase III trials in progress (CAMMS 323, 324).
The FDA indicated that Advancis' recently concluded Phase III clinical trial in adults and adolescents, along with the company's Phase I pharmacokinetic studies, results from the Company's prior adult and adolescent Amoxicillin PULSYS
Phase III trial, and existing academic literature would be sufficient to support an NDA filing.
A
phase III trial with oral cladribine has been started.
In the
phase III trial, which included 476 women from 13 sites, 461 patients had worn the device for 1 year, 403 for 2 years, and 38 for 3 years.